Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Barbara Adams Krolak: Do GLP-1s Affect Blood Clot Risk?
Barbara Adams Krolak /LinkedIn
Sep 17, 2026, 16:16

Barbara Adams Krolak: Do GLP-1s Affect Blood Clot Risk?

Barbara Adams Krolak, Marketing Manager at ISTH, shared International Society on Thrombosis and Haemostasis (ISTH)‘s post on LinkedIn, adding:

“We are very excited to drop this new episode of the ISTH Pulse Podcast that explores a trending question we’re hearing: Do GLP-1s affect blood clot risk?

Listen now to hear what the experts have to say about this.”

International Society on Thrombosis and Haemostasis (ISTH) shared a post on LinkedIn:

“GLP-1 receptor agonists are increasingly used in the treatment of type 2 diabetes and obesity, but what do we know about their potential relationship with venous thromboembolism (VTE)?

Tune in to a special episode, presented in collaboration with Vasculearn Network, to hear host Julia Sandrin Gauer joined by Dr. Christian Ruff and Dr. Rushad Patell to discuss the latest evidence, unanswered questions and practical considerations for clinicians, including:

  • Potential effects on clotting risk
  • The roles of weight loss and cardiometabolic health
  • Anti-inflammatory mechanisms
  • Differences across GLP-1 and dual GIP/GLP-1 therapies
  • Gaps in the current evidence.

Listen now and let us know what you think.”

Barbara Adams Krolak: Do GLP-1s Affect Blood Clot Risk?

Stay updated with Hemostasis Today.

 

Barbara Adams Krolak Christian Ruff GLP-1s Health Hematology Hemostasis Hemostasis News Hemostasis Today International Society on Thrombosis and Haemostasis ISTH Julia Sandrin Gauer Medicine Rushad Patell
NewsFeed